Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit

Affiliations

• ¹ Department of Dermatology, University Hospital of Nice, Nice, France.
• ² Team 12, Centre Méditerranéen de Médecine Moléculaire, INSERM, U1065, Nice, France.
• ³ Team 1, Centre Méditerranéen de Médecine Moléculaire, INSERM, U1065, Nice, France.
• ⁴ Department of Dermatology, Clinical Research Center, Archet Hospital, Nice, France.
• ⁵ Department of Clinical Research and Innovation, University Hospital of Nice, Nice, France.
• ⁶ Department of Dermatology, CHRU de Tours, University Francois Rabelais of Tours, Tours, France.
• ⁷ Department of Dermatology, University Hospital of Amiens, Amiens, France.
• ⁸ Department of Dermatology, University Hospital of Caen, Caen, France.
• ⁹ Department of Dermatology, University Hospital of Paris, Hospital Bichat, Nice, France.
• ¹⁰ Department of Dermatology, University Hospital of Besançon, Besançon, France.
• ¹¹ Department of Dermatology, University Hospital of Nancy, Nancy, France.
• ¹² Department of Oncology, Antoine Lacassagne Cancer Center, University of Nice-Sophia, Nice, France.
• ¹³ Laboratory of Clinical and Experimental Pathology and Human Biobank, Nice University Hospital, Nice, France.
• ¹⁴ Faculty of Medicine, INSERM 1081 Team 3 IRCAN, University of Nice Sophia Antipolis, Nice, France.